Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1999 4
2000 4
2001 2
2003 3
2004 4
2005 4
2006 4
2007 2
2008 2
2009 1
2010 5
2011 7
2012 8
2013 2
2014 14
2015 11
2016 16
2017 10
2018 8
2019 17
2020 26
2021 17
2022 12
2023 19

Text availability

Article attribute

Article type

Publication date

Search Results

185 results

Results by year

Filters applied: . Clear all
Page 1
Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer.
Cassier PA, Navaridas R, Bellina M, Rama N, Ducarouge B, Hernandez-Vargas H, Delord JP, Lengrand J, Paradisi A, Fattet L, Garin G, Gheit H, Dalban C, Pastushenko I, Neves D, Jelin R, Gadot N, Braissand N, Léon S, Degletagne C, Matias-Guiu X, Devouassoux-Shisheboran M, Mery-Lamarche E, Allard J, Zindy E, Decaestecker C, Salmon I, Perol D, Dolcet X, Ray-Coquard I, Blanpain C, Bernet A, Mehlen P. Cassier PA, et al. Among authors: devouassoux shisheboran m. Nature. 2023 Aug;620(7973):409-416. doi: 10.1038/s41586-023-06367-z. Epub 2023 Aug 2. Nature. 2023. PMID: 37532934 Free PMC article. Clinical Trial.
Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group.
Croce S, Devouassoux-Shisheboran M, Pautier P, Ray-Coquard I, Treilleux I, Neuville A, Arnould L, Just PA, Belda MALF, Averous G, Leroux A, Mery E, Loussouarn D, Weinbreck N, Le Guellec S, Mishellany F, Morice P, Guyon F, Genestie C. Croce S, et al. Among authors: devouassoux shisheboran m. Gynecol Oncol. 2022 Sep 13:S0090-8258(22)00515-7. doi: 10.1016/j.ygyno.2022.07.031. Online ahead of print. Gynecol Oncol. 2022. PMID: 36114030 Review.
Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).
Bourdel N, Huchon C, Abdel Wahab C, Azaïs H, Bendifallah S, Bolze PA, Brun JL, Canlorbe G, Chauvet P, Chereau E, Courbiere B, De La Motte Rouge T, Devouassoux-Shisheboran M, Eymerit-Morin C, Fauvet R, Gauroy E, Gauthier T, Grynberg M, Koskas M, Larouzee E, Lecointre L, Levêque J, Margueritte F, Mathieu D'argent E, Nyangoh-Timoh K, Ouldamer L, Raad J, Raimond E, Ramanah R, Rolland L, Rousset P, Rousset-Jablonski C, Thomassin-Naggara I, Uzan C, Zilliox M, Daraï E. Bourdel N, et al. Among authors: devouassoux shisheboran m. Eur J Obstet Gynecol Reprod Biol. 2021 Jan;256:492-501. doi: 10.1016/j.ejogrb.2020.11.045. Epub 2020 Nov 20. Eur J Obstet Gynecol Reprod Biol. 2021. PMID: 33262005
[Gynecopathology: introduction].
Devouassoux-Shisheboran M. Devouassoux-Shisheboran M. Ann Pathol. 2012 Jun;32(3):184. doi: 10.1016/j.annpat.2012.04.001. Epub 2012 May 21. Ann Pathol. 2012. PMID: 22748332 French. No abstract available.
[Gestational trophoblastic disease].
Allias F, Bolze PA, Gaillot-Durand L, Devouassoux-Shisheboran M; réseau des maladies trophoblastiques gestationnelles. Allias F, et al. Among authors: devouassoux shisheboran m. Ann Pathol. 2014 Dec;34(6):434-47. doi: 10.1016/j.annpat.2014.09.004. Epub 2014 Nov 14. Ann Pathol. 2014. PMID: 25499859 Review. French.
Uterine inflammatory myofibroblastic tumor.
Karpathiou G, Devouassoux-Shisheboran M, Stolnicu S, Chauleur C, Péoc'h M. Karpathiou G, et al. Among authors: devouassoux shisheboran m. Pathol Res Pract. 2023 Feb;242:154335. doi: 10.1016/j.prp.2023.154335. Epub 2023 Jan 23. Pathol Res Pract. 2023. PMID: 36706588 Review.
[Ovarian epithelial tumors: Introduction].
Devouassoux-Shisheboran M. Devouassoux-Shisheboran M. Ann Pathol. 2020 Jun;40(3):186-187. doi: 10.1016/j.annpat.2020.02.002. Epub 2020 May 5. Ann Pathol. 2020. PMID: 32386877 Review. French. No abstract available.
The Increasing Prognostic and Predictive Roles of the Tumor Primary Chemosensitivity Assessed by CA-125 Elimination Rate Constant K (KELIM) in Ovarian Cancer: A Narrative Review.
Lauby A, Colomban O, Corbaux P, Peron J, Van Wagensveld L, Gertych W, Bakrin N, Descargues P, Lopez J, Kepenekian V, Glehen O, Philip CA, Devouassoux-Shisheboran M, Tod M, Freyer G, You B. Lauby A, et al. Among authors: devouassoux shisheboran m. Cancers (Basel). 2021 Dec 25;14(1):98. doi: 10.3390/cancers14010098. Cancers (Basel). 2021. PMID: 35008262 Free PMC article. Review.
Pathobiology of ovarian carcinomas.
Devouassoux-Shisheboran M, Genestie C. Devouassoux-Shisheboran M, et al. Chin J Cancer. 2015 Jan;34(1):50-5. doi: 10.5732/cjc.014.10273. Chin J Cancer. 2015. PMID: 25556618 Free PMC article. Review.
185 results